Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

February 29, 2008

Study Completion Date

September 30, 2009

Conditions
Colorectal NeoplasmsLiver Neoplasms
Interventions
DRUG

Irinotecan + 5 FU + folinic acid

irinotecan 180 mg/m2 folinic acid 400 mg/m2 (DL) followed by 5 FU bolus 400 mg/m2 5 FU continuous infusion (2400 mg/m2 over 46 hours) every 2 weeks

DRUG

Folinic Acid + 5 FU

folinic acid 400 mg/m2(DL) followed by bolus 5 FU 400mg/m2 5 FU continuous infusion (2400 mg/m2 over 46 hours) every 2 weeks

Trial Locations (66)

2100

Pfizer Investigational Site, Copenhagen

3010

Pfizer Investigational Site, Bern

4200

Pfizer Investigational Site, Porto

7500

Pfizer Investigational Site, Panorama

8800

Pfizer Investigational Site, Roeselare

9000

Pfizer Investigational Site, Ghent

13005

Pfizer Investigational Site, Marseille

13273

Pfizer Investigational Site, Marseille

20089

Pfizer Investigational Site, Rozzano (Mi)

20246

Pfizer Investigational Site, Hamburg

25123

Pfizer Investigational Site, Brescia

26133

Pfizer Investigational Site, Oldenburg

28041

Pfizer Investigational Site, Madrid

29100

Pfizer Investigational Site, Piacenza

30900

Pfizer Investigational Site, Nîmes

31059

Pfizer Investigational Site, Toulouse

33053

Pfizer Investigational Site, Latisana, UD

34295

Pfizer Investigational Site, Montpellier

35042

Pfizer Investigational Site, Rennes

35100

Pfizer Investigational Site, Padua

38043

Pfizer Investigational Site, Grenoble

39008

Pfizer Investigational Site, Santander

39104

Pfizer Investigational Site, Magdeburg

39120

Pfizer Investigational Site, Magdeburg

41012

Pfizer Investigational Site, Carpi

41014

Pfizer Investigational Site, Seville

42100

Pfizer Investigational Site, Reggio Emilia

43100

Pfizer Investigational Site, Parma

55131

Pfizer Investigational Site, Mainz

63058

Pfizer Investigational Site, Clermont-Ferand Cedex 1

64239

Pfizer Investigational Site, Tel Aviv

67091

Pfizer Investigational Site, Strasbourg

68024

Pfizer Investigational Site, Colmar

72076

Pfizer Investigational Site, Tübingen

76100

Pfizer Investigational Site, Rehovot

80054

Pfizer Investigational Site, Amiens

83092

Pfizer Investigational Site, Donetsk

84000

Pfizer Investigational Site, Avignon

91054

Pfizer Investigational Site, Erlangen

93042

Pfizer Investigational Site, Regensburg

411764

Pfizer Investigational Site, Goyang

DK-2730

Pfizer Investigational Site, Herlev

DK5000

Pfizer Investigational Site, Odense

Unknown

Pfizer Investigational Site, Boulogne-Billancourt

Pfizer Investigational Site, Hong Kong

Pfizer Investigational Site, Haifa

Pfizer Investigational Site, Petah Tikva

Pfizer Investigational Site, Tel Litwinsky

Pfizer Investigational Site, Taoyuan District

13273 CEDEX 09

Pfizer Investigational Site, Marseille

34298 CEDEX 5

Pfizer Investigational Site, Montpellier

06031

Pfizer Investigational Site, Nice

03048

Pfizer Investigational Site, Cottbus

06847

Pfizer Investigational Site, Dessau

04103

Pfizer Investigational Site, Leipzig

700-721

Pfizer Investigational Site, Daegu

120-753

Pfizer Investigational Site, Seoul

135-710

Pfizer Investigational Site, Seoul

139-240

Pfizer Investigational Site, Seoul

08036

Pfizer Investigational Site, Barcelona

08907

Pfizer Investigational Site, L'Hospitalet de Llobregat

413 45

Pfizer Investigational Site, Gothenburg

03922

Pfizer Investigational Site, Kiev

N18 1QX

Pfizer Investigational Site, London

SO16 6YD

Pfizer Investigational Site, Southampton

GU2 7XX

Pfizer Investigational Site, Surrey

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00143403 - Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer | Biotech Hunter | Biotech Hunter